TY - JOUR
T1 - Medicinal plants in the treatment of urolithiasis
T2 - A review
AU - Osman, Wadah
AU - Elsadig, Tasneem
AU - Mirghani, Mohamed
AU - Mohamed, Mona S.
AU - Elamin, Khaled M.
AU - Alqarni, Mohammed H.
AU - Foudah, Ahmed I.
AU - Ashour, Ahmed
AU - Elsaid Sherif, Asmaa
N1 - Publisher Copyright:
© 2025 Journal of Pharmacy & Pharmacognosy Research
PY - 2025/1
Y1 - 2025/1
N2 - Context: Urolithiasis is recognized globally as the second most burdensome renal disorder, imposing significant costs on healthcare systems. Aims: To analyze scientific research on medicinal plants that demonstrate potential effects in the treatment of urolithiasis. Methods: Articles that described preparation methods, plant organs used, and phytoconstituents and essential oils responsible for anti-urolithiatic activity were highlighted. Articles were extracted from Google Scholar, Science Direct, and PubMed using specific keywords. Results: A total of 81 articles were selected. All plant organs provided anti-urolithiatic extracts, with leaves contributing 22%, followed by whole plant (17%), seeds (14%), fruits (11%), flowers (8%), aerial parts (7%), barks (4%), rhizomes (4%), and stems (3%). Cold extraction methods were used in 55% of articles, while hot methods were used in 45%. Phenolic and polyphenolic compounds were predominant, particularly flavonoids (25%); in addition to saponin glycosides (18%), alkaloids (11%), and others. Hydro-alcohols were the most utilized solvents, indicating that many polar compounds are readily soluble in urine. This suggests a potential mechanism for their action in the eradication or prevention of kidney stones. Conclusions: Further research on synergistic formulations of these constituents and their pharmacokinetic and pharmacodynamic profiles is recommended. Extensive research is required to examine the ability of essential oils in the eradication of kidney stones, especially those with high simple phenolic and hydroxyl content. Various active phytochemical groups necessitate various modes of action, emphasizing the unique properties of medicinal plants in drug discovery and development.
AB - Context: Urolithiasis is recognized globally as the second most burdensome renal disorder, imposing significant costs on healthcare systems. Aims: To analyze scientific research on medicinal plants that demonstrate potential effects in the treatment of urolithiasis. Methods: Articles that described preparation methods, plant organs used, and phytoconstituents and essential oils responsible for anti-urolithiatic activity were highlighted. Articles were extracted from Google Scholar, Science Direct, and PubMed using specific keywords. Results: A total of 81 articles were selected. All plant organs provided anti-urolithiatic extracts, with leaves contributing 22%, followed by whole plant (17%), seeds (14%), fruits (11%), flowers (8%), aerial parts (7%), barks (4%), rhizomes (4%), and stems (3%). Cold extraction methods were used in 55% of articles, while hot methods were used in 45%. Phenolic and polyphenolic compounds were predominant, particularly flavonoids (25%); in addition to saponin glycosides (18%), alkaloids (11%), and others. Hydro-alcohols were the most utilized solvents, indicating that many polar compounds are readily soluble in urine. This suggests a potential mechanism for their action in the eradication or prevention of kidney stones. Conclusions: Further research on synergistic formulations of these constituents and their pharmacokinetic and pharmacodynamic profiles is recommended. Extensive research is required to examine the ability of essential oils in the eradication of kidney stones, especially those with high simple phenolic and hydroxyl content. Various active phytochemical groups necessitate various modes of action, emphasizing the unique properties of medicinal plants in drug discovery and development.
KW - anti-urolithiatic activity
KW - essential oils
KW - extraction methods
KW - kidney stones
KW - nephrolithiasis
KW - phytochemicals
KW - plant organs
UR - https://www.scopus.com/pages/publications/105024380972
U2 - 10.56499/jppres25.2330_13.6.1819
DO - 10.56499/jppres25.2330_13.6.1819
M3 - Review article
AN - SCOPUS:105024380972
SN - 0719-4250
VL - 13
SP - 1819
EP - 1846
JO - Journal of Pharmacy and Pharmacognosy Research
JF - Journal of Pharmacy and Pharmacognosy Research
IS - 6
ER -